Gene · 1573
Papers1,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Influence of 3-dimensional architecture and coculture on in vitro CYP enzyme metabolism and induction: Benchmarking human hepatic spheroids for studies in drug development. | Drug Metab Dispos | 2026 | 41604847 | PubTator, text mining | PubMed |
| Epoxy-oxylipins direct monocyte fate in inflammatory resolution in humans. | Nat Commun | 2026 | 41545341 | PubTator, text mining | PubMed |
| Novel cytochrome P450 2J isoforms in tree shrews are functional drug-metabolising enzymes involved in ebastine and astemizole oxidation. | Xenobiotica | 2026 | 41482941 | PubTator, text mining | PubMed |
| Effects of resveratrol on CYP450-derived arachidonic acid metabolites and mRNA gene expression in human endothelial HUVEC cells. | J Complement Integr Med | 2026 | 41423909 | PubTator, text mining | PubMed |
| Extreme variability in linezolid concentrations in the ICU: A case for routine therapeutic drug monitoring. | Am J Health Syst Pharm | 2026 | 40882010 | PubTator, text mining | PubMed |
| Mass spectrometry in ocular drug research. | Mass Spectrom Rev | 2026 | 37530668 | PubTator, text mining | PubMed |
| Regulation of P450-derived epoxy fatty acids in cardiovascular diseases. | Redox Biochem Chem | 2025 | 42006847 | PubTator, text mining | PubMed |
| CYP2J2 links metabolic reprogramming to colorectal cancer progression. | Arch Med Sci | 2025 | 41676422 | PubTator, text mining | PubMed |
| Construction of a competitive endogenous RNA network and identification of potential regulatory axes in hypertrophic cardiomyopathy. | Front Cardiovasc Med | 2025 | 41602333 | PubTator, text mining | PubMed |
| Comprehensive proteome profiling of cytochrome P450 isoforms in cancer models. | Clin Proteomics | 2025 | 41174467 | PubTator, text mining | PubMed |
| Integrated Analysis of Single-cell and Bulk-RNA Sequencing Data to Identify Redox-related Genes as Prognostic Biomarkers and Therapeutic Targets of Lung Adenocarcinoma With Osimertinib Resistance. | Front Biosci (Landmark Ed) | 2025 | 41074434 | PubTator, text mining | PubMed |
| Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8. | Drug Metab Pharmacokinet | 2025 | 41027245 | PubTator, text mining | PubMed |
| An integrative bioinformatic and Mendelian randomization study exploring the role of polyunsaturated fatty acid metabolism in laryngeal cancer. | Discov Oncol | 2025 | 41020923 | PubTator, text mining | PubMed |
| Clozapine-associated perturbation of arachidonic acid metabolism: A future direction for clozapine-induced cardiotoxicity. | Toxicol Lett | 2025 | 40914282 | PubTator, text mining | PubMed |
| Effect of Gene Polymorphism on the Pharmacokinetics and Clinical Outcomes of Rivaroxaban: State-of-the-Art Review. | Drug Des Devel Ther | 2025 | 40896201 | PubTator, text mining | PubMed |
| Atypical mesenchyme in congenital pulmonary airways malformation: a promising new focus. | Respir Res | 2025 | 40859353 | PubTator, text mining | PubMed |
| Bridging regional neurovascular unit heterogeneity and cognitive function: a review. | Fluids Barriers CNS | 2025 | 40836329 | PubTator, text mining | PubMed |
| Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomics. | Nat Commun | 2025 | 40835825 | PubTator, text mining | PubMed |
| Construction of refined CYP2D6-Template system for studies of its metabolism and inhibition. | Drug Metab Pharmacokinet | 2025 | 40816236 | PubTator, text mining | PubMed |
| Analysis of immune characteristics and inflammatory mechanisms in COPD patients: a multi-layered study combining bulk and single-cell transcriptome analysis and machine learning. | Front Med (Lausanne) | 2025 | 40761855 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1573/papers?page=2